EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Syndecan-1 Plays a Role in the Pathogenesis of Sjögren’s Disease by Inducing B-Cell Chemotaxis through CXCL13–Heparan Sulfate Interaction

Nan Young Lee iD, Hirut Yadeta Ture, Eun Ju Lee, Ji Ae Jang, Gunwoo Kim, Eon Jeong Nam iD

International Journal of Molecular Sciences · 29.08.2024 · 25 (17) · 9375

DOI: 10.3390/ijms25179375 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.08.2024. Verfasst von Nan Young Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pathology, School of Medicine, Kyungpook National University, Daegu 41405, Republic of Korea. Hauptthemen laut MEDLINE: Syndecan-1, Chemokine CXCL13, B-Lymphocytes, Sjogren's Syndrome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In Sjögren’s disease (SjD), the salivary glandular epithelial cells can induce the chemotaxis of B cells by secreting B-cell chemokines such as C-X-C motif chemokine ligand 13 (CXCL13). Syndecan-1 (SDC-1) is a major transmembrane heparan sulfate proteoglycan (HSPG) predominantly expressed on epithelial cells that binds to and regulates heparan sulfate (HS)-binding molecules, including chemokines. We aimed to determine whether SDC-1 plays a role in the pathogenesis of SjD by acting on the binding of HS to B-cell chemokines. To assess changes in glandular inflammation and SDC-1 concentrations in the submandibular gland (SMG) and blood, female NOD/ShiLtJ and sex- and age-matched C57BL/10 mice were used. In the SMG of NOD/ShiLtJ mice, inflammatory responses were identified at 8 weeks of age, but increased SDC-1 concentrations in the SMG and blood were observed at 6 weeks of age, when inflammation had not yet started. As the inflammation of the SMG worsened, the SDC-1 concentrations in the SMG and blood increased. The expression of the CXCL13 and its receptor C-X-C chemokine receptor type 5 (CXCR5) began to increase in the SMG at 6 weeks of age and continued until 12 weeks of age. Immunofluorescence staining in SMG tissue and normal murine mammary gland cells confirmed the co-localization of SDC-1 and CXCL13, and SDC-1 formed a complex with CXCL13 in an immunoprecipitation assay. Furthermore, NOD/ShiLtJ mice were treated with 5 mg/kg HS intraperitoneally thrice per week for 6–10 weeks of age, and the therapeutic effects in the SMG were assessed at the end of 10 weeks of age. NOD/ShiLtJ mice treated with HS showed attenuated salivary gland inflammation with reduced B-cell infiltration, germinal center formation and CXCR5 expression. These findings suggest that SDC-1 plays a pivotal role in the pathogenesis of SjD by binding to CXCL13 through the HS chain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Syndecan-1Chemokine CXCL13B-LymphocytesSjogren's SyndromeHeparan SulfateAnimalsMiceFemaleMice, Inbred C57BLChemotaxisMice, Inbred NODSubmandibular GlandHumansReceptors, CXCR5Protein Binding

Stichwörter der Autor:innen

B cellCXCL13Sjögren’s diseaseepithelial cellsyndecan-1

Substanzen

Syndecan-1Chemokine CXCL13Heparan SulfateReceptors, CXCR5Cxcl13 protein, mouseSdc1 protein, mouse

Autor:innen und Institutionen

  • Department of Clinical Pathology, School of Medicine, Kyungpook National University, Daegu 41405, Republic of Korea.
  • Division of Rheumatology, Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu 41405, Republic of Korea.
  • Laboratory for Arthritis and Bone Biology, Fatima Research Institute, Daegu Fatima Hospital, Daegu 41199, Republic of Korea.

ORCID-Profile: Nan Young Lee, Eon Jeong Nam

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Lee, N. Y., Ture, H. Y., Lee, E. J., Jang, J. A., Kim, G., & Nam, E. J. (2024). Syndecan-1 Plays a Role in the Pathogenesis of Sjögren’s Disease by Inducing B-Cell Chemotaxis through CXCL13–Heparan Sulfate Interaction. International Journal of Molecular Sciences, 25(17), 9375. https://doi.org/10.3390/ijms25179375

Vancouver

Lee NY, Ture HY, Lee EJ, Jang JA, Kim G, Nam EJ. Syndecan-1 Plays a Role in the Pathogenesis of Sjögren’s Disease by Inducing B-Cell Chemotaxis through CXCL13–Heparan Sulfate Interaction. International Journal of Molecular Sciences. 2024;25(17):9375. doi:10.3390/ijms25179375

BibTeX
@article{Lee2024,
  author = {Lee, Nan Young and Ture, Hirut Yadeta and Lee, Eun Ju and Jang, Ji Ae and Kim, Gunwoo and Nam, Eon Jeong},
  title = {Syndecan-1 Plays a Role in the Pathogenesis of Sjögren’s Disease by Inducing B-Cell Chemotaxis through CXCL13–Heparan Sulfate Interaction},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {17},
  pages = {9375},
  doi = {10.3390/ijms25179375}
}
Kostenlos starten →